MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

PTUPB

CAS No. : 1287761-01-6

MCE 国际站：PTUPB

产品活性：PTUPB 是一种强效的 sEH 和 COX-2 的双向抑制剂，IC₅₀ 值分别为 0.9 nM 和 1.26 μM。

研究领域：Immunology/Inflammation

作用靶点：COX

In Vitro: PTUPB (1-10 μM; 24 hours) shows an inhibitory activity against human 5-LOX, exhibits a 83% and 44% inhibition at 10 μM and 1 μM, respectively.
PTUPB (10-20 μM; 72 hours) has minimal inhibitory effects on cell proliferation in multiple cancer cell lines, including human melanoma cell and a transformed endothelial cell, whereas it potently inhibits HUVEC proliferation after 3 days of application.
PTUPB (10-20 μM; 72 hours) induces cell cycle arrest at the G0/1 phase at different various. The percentage of cell number of PTUPB are 65.15%, 66.87%,and 65.91% at 10 μM, 15 μM, and 20 μM, respectively.

In Vivo: PTUPB (subcutaneous injection; 30 mg/kg; 4 weeks) inhibits LLC tumor growth by 70-83% and exhibits with no overt toxicity, such as any weight loss when it is compared with the control group. After a period of treatment, the peak plasma concentration of PTUPB is high.
PTUPB (subcutaneous injection; 5 mg/kg; once daily; 12 weeks) ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation. It reduces body weight, liver weight, liver triglyceride and cholesterol content. It also decreases the expression of lipolytic/lipogenic and lipid uptake related genes.

相关产品：Covalent Screening Library Plus  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Anti-Cancer Compound Library  |  Anti-Aging Compound Library  |  Covalent Screening Library  |  Pyroptosis Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Anti-Colorectal Cancer Compound Library   |  Antidepressant Compound Library  |  Anti-Prostate Cancer Compound Library  |  Heterocyclic Compound Library  |  Highly Selective Inhibitors Library  |  Meloxicam-d₃-1  |  4-Methylamino antipyrine hydrochloride  |  Vedaprofen-d₃  |  Pelubiprofen-¹³C,d₃  |  N-tert-Butyl-α-phenylnitrone-d₁₄  |  Tepoxalin  |  Ampyrone  |  Pectolinarigenin  |  Ermanin  |  Aceclofenac-d₄  |  SC-58125  |  Salicylic acid-¹³C₆  |  (±)-Naproxen-d₃-1  |  Dehydroevodiamine hydrochloride  |  Aspirin-d₄  |  Asaraldehyde  |  Broussonin E  |  (-)-Epicatechin  |  COX-2/15-LOX-IN-1  |  20(S)-Ginsenoside Rg3  |  Ginsenoside Rd  |  Salicylic acid-d₆  |  TFAP  |  Hydrangenol  |  Alminoprofen  |  Acetaminophen-d₃  |  FPL 62064  |  Crocin II  |  AG-024322  |  Ketoprofen-¹³C,d₃

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。